Posted in | News | Mining Business

Forbes Coal Agrees to Acquire Portion of Ikwezi Mining Right over Alleen No. 2 Property

Forbes & Manhattan Coal Corp. ("Forbes Coal" or the "Company") has entered into an agreement with Ikwezi Mining Proprietary Limited ("Ikwezi") for the acquisition of a portion of the Ikwezi mining right over the property known as Alleen No. 2, located north of Dundee in the Kwa-Zulu Natal province in South Africa, adjacent to Forbes Coal's current Magdalena opencast operations ("Alleen No. 2").

Zinoju Coal Proprietary Limited, a subsidiary of Forbes Coal, will acquire Alleen No. 2 for a purchase price of ZAR 8 million (CAD$0.8 million), based on the estimated run of mine that can be extracted from the mining right area. If the run of mine actually extracted exceeds the agreed upon production threshold, Ikwezi is entitled to receive a top-up payment equivalent to ZAR 10 (CAD$1) per tonne extracted which exceeds the production threshold.

The agreement is subject to the Company receiving written consent from the Minister of Mineral Resources of the application of sale of the mining right from Ikwezi and the application to purchase the mining right by the Company in terms of section 102 of the Mineral and Petroleum Resources Development Act on or before 30 April 2014.

About Forbes Coal

Forbes Coal is a coal producer in southern Africa. It holds a majority interest in two operating mines through its 100% interest in Forbes Coal (Pty) Ltd., a South African company which has a 70% interest in Zinoju Coal (Pty) Ltd. ("Zinoju"). Zinoju holds a 100% interest in the Magdalena bituminous mine and the Aviemore anthracite mine in South Africa. Forbes Coal has an experienced coal-focused management team.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.